NCT04022109Recruiting
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Source: ClinicalTrials.gov · Last updated 26 Jul 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 12 Jul 2019
- Start date
- 1 Nov 2019
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- University of Latvia
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT04022109
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 1 Nov 2019 to the primary completion date, 31 Dec 2022
- 5 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known other active cancer
Other
- Ventilation problems, airway obstruction
- Unwillingness or inability to co-operate
Who the study is looking for
- Patients with verified gastric cancer (Group 1 \& 2)
- Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
- Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
- Motivation to participate in the study
- Physical status allowing volatile marker sampling and other procedures within the protocol
- Signed consent
Age in the registry: 18 years to - · Sex: All
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| A.C. Camargo Cancer Center Coordinator of this site? Confirm its status | São Paulo | Brazil | Recruiting |
| Pontificia Universidad Catolica de Chile Coordinator of this site? Confirm its status | Santiago | Chile | Not yet recruiting |
| Centro Javeriano de Oncología, San Ignacio University Hospital Coordinator of this site? Confirm its status | Bogotá | Colombia | Not yet recruiting |
| Institute of Clinical and Preventive Medicine, University of Latvia Coordinator of this site? Confirm its status | Riga | Latvia | Recruiting |
| National Cancer Institute of Ukraine Coordinator of this site? Confirm its status | Kiev | Ukraine | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.